Partial directly observed therapy with ombitasvir/paritaprevir based regimens allows for successful treatment of patients on daily supervised methadone
Saved in:
Published in | Journal of hepatology Vol. 66; no. 1; p. S282 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Author | Heydtmann, M Barclay, S.T Boyle, A Marra, F Fleming, C Fox, R Morris, J Reilly, E Cairns, H |
---|---|
Author_xml | – sequence: 1 fullname: Boyle, A – sequence: 2 fullname: Marra, F – sequence: 3 fullname: Fox, R – sequence: 4 fullname: Morris, J – sequence: 5 fullname: Fleming, C – sequence: 6 fullname: Reilly, E – sequence: 7 fullname: Heydtmann, M – sequence: 8 fullname: Cairns, H – sequence: 9 fullname: Barclay, S.T |
BookMark | eNo9kNtqGzEQhkVIIM7hEQK6bC-2kSzt6aZQTNMWDC00uRaz2lGsZL1aNFoHP0leN7JdejMHZuabmf-KnY9hRMbupPgihazu_2bTFM2ybj7J-rMSTSMLfcYWshKiEJWW52zxv-WSXRG9CCGUaPWCvf-BmDwMvPcRbRr2PHSEcYc9TxuMMO35m08bHradT0A7H-8niDmcIuaEd0C5NeKz3-JIHIYhvBF3IXKarUUiNw88RYSU64kHxydIPofEw8h78HkjzVPe6A-gLaYN9Pm9G3bhYCC8_eev2dPD98fVz2L9-8ev1bd1YWWpdNHpJWhdN22lS4utrUopUHeqaytX5dehU661ret7sLJTsneyVQK0ANUqLJfqmpUnro2BKKIzU_RbiHsjhTmoa47qmoN0RtbmqK7Ree7raQ7zcTuP0djBj97C8Ip7pJcwxzHfbaShpREnyIEh6yNBqw_Oe4lk |
CitedBy_id | crossref_primary_10_1111_liv_13949 crossref_primary_10_1038_nrgastro_2017_106 crossref_primary_10_1093_cid_ciz696 crossref_primary_10_1016_j_idc_2018_02_003 crossref_primary_10_1016_j_idc_2018_02_001 crossref_primary_10_1016_j_jhep_2018_03_026 crossref_primary_10_7448_IAS_20_1_22146 |
ContentType | Journal Article |
Copyright | European Association for the Study of the Liver |
Copyright_xml | – notice: European Association for the Study of the Liver |
DBID | AAYXX CITATION |
DOI | 10.1016/S0168-8278(17)30881-4 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1600-0641 |
EndPage | S282 |
ExternalDocumentID | 10_1016_S0168_8278_17_30881_4 1_s2_0_S0168827817308814 |
GroupedDBID | - 0R 1 1- 1B1 1P 1RT 1~. 1~5 29K 3O- 4.4 457 4G. 53G 55 5GY 5RE 5VS 7-5 71M 8P 9JM AABNK AACTN AAEDT AAIAV AAIKJ AAKOC AALMO AALRI AAOAW AAQFI AAQQT AAQXK AAXUO ABBQC ABFLS ABFNM ABFRF ABLVK ABMAC ABMZM ABPIF ABPTK ABQIS ABWYI ABXDB ABYKQ ACDAQ ACGFO ACGFS ACIUM ACRLP ADALY ADBBV ADEZE AEBSH AEFWE AEKER AENEX AEVXI AFCTW AFFNX AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AZFZN BKOJK BLXMC BNPGV CS3 D-I DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FO G- G-2 G-Q GBLVA GJ HDZ HMK HMO HVGLF HX HZ IHE IPNFZ J1W K KOM LCYCR LZ1 M M27 M41 MJL MO0 N9A O-L O9- OAUVE OC. ON0 OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K TEORI UV1 WUQ X7M YOC Z5R ZGI --- --K --M .1- .55 .FO .GJ .~1 0R~ 1P~ 8P~ AAEDW AAXKI AAYXX ABJNI ADMUD ADVLN AFJKZ AKRWK AXJTR CITATION FYGXN HX~ HZ~ ~G- |
ID | FETCH-LOGICAL-c1534-b42a44789645ce9c6510e4b3b96f6064ab3f9c9fddac1b31df1930a40a393e523 |
ISSN | 0168-8278 |
IngestDate | Thu Sep 26 17:30:50 EDT 2024 Thu Aug 18 17:14:30 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1534-b42a44789645ce9c6510e4b3b96f6064ab3f9c9fddac1b31df1930a40a393e523 |
ParticipantIDs | crossref_primary_10_1016_S0168_8278_17_30881_4 elsevier_clinicalkeyesjournals_1_s2_0_S0168827817308814 |
PublicationCentury | 2000 |
PublicationDate | 2017 2017-00-00 |
PublicationDateYYYYMMDD | 2017-01-01 |
PublicationDate_xml | – year: 2017 text: 2017 |
PublicationDecade | 2010 |
PublicationTitle | Journal of hepatology |
PublicationYear | 2017 |
SSID | ssj0003094 |
Score | 2.255529 |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | S282 |
SubjectTerms | Gastroenterology and Hepatology |
Title | Partial directly observed therapy with ombitasvir/paritaprevir based regimens allows for successful treatment of patients on daily supervised methadone |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0168827817308814 |
Volume | 66 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWIiEuiKcoL_nAARQlTWLn4WNBVFWlIkRbqbfITmyoBJtVkm1VDvwNxL9lxs5roUKUS7Sy1pMo82XGHn8zQ8hLKUySMRP7oTTS5yYRvjKsgq0Kl9qkKi81Jjgfvk_3T_jBaXK6WPycsZbWnQrKb1fmlfyPVmEM9IpZstfQ7CgUBuA36BeuoGG4_pOOP-CYPWVBu_Xl0qsVBlm15URisQAXZq2_qrNOtudnjW21i-GAlWX3eujDMH3lE9b4bz08hL-wBRq8dm07KSKDeeKiIzva1WG1hwyVxNhIu16hvUFB2I5aVvVyk140LXk_g-_rNuL4b-pLx2feDabYeGN7H3l741DvIj9O_6mbxhVHOAjmcQuXoDkEMdPcz2PXumewwq73ygbanEk9il13oj9svQs7HI3SsLAVxk8YGM6oTx3aqK_9m98b2YgzoluaFyiqiLLCiin4DXIzzmATCaYy-D6xh1go-rLx7uZTctjO9ESvoux1_zRXL3tmS5nju-ROrxC66wB1jyz08j65ddizLB6QHz2u6IArOuCK9riiiCs64WpnjipqUUUHVFGHKgqoohOq6IgqWhs6oIrWS2pRRSdU0RFVD8nJ3rvjt_t-38DDL8GRcl_xWHKe5SLlSalFmYID0FwxJVIDG2cuFTOiFKaqZBkpFlUGthOh5KFkgukkZo_I1hLEPyaUJTrNE51kUVXyvGKKiYqV2EAtY7DGT7ZJMLzfYuXqtBR_1es2yQYtFEMSMrhN3fbfd1tERRsXoZuNk6PMTuVPrnurp-Q2fgAucPeMbHXNWj-HpWynXlhQ_QJ6DKFu |
link.rule.ids | 315,786,790,4043,27956,27957,27958 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Partial+directly+observed+therapy+with+ombitasvir%2Fparitaprevir+based+regimens+allows+for+successful+treatment+of+patients+on+daily+supervised+methadone&rft.jtitle=Journal+of+hepatology&rft.au=Boyle%2C+A.&rft.au=Marra%2C+F.&rft.au=Fox%2C+R.&rft.au=Morris%2C+J.&rft.date=2017&rft.issn=0168-8278&rft.volume=66&rft.issue=1&rft.spage=S282&rft_id=info:doi/10.1016%2FS0168-8278%2817%2930881-4&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_S0168_8278_17_30881_4 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01688278%2FS0168827817X00020%2Fcov150h.gif |